MR imaging-based volumetry in patients with early-treated phenylketonuria

American Journal of Neuroradiology

Volumn 26, Issue 7, 2005, Pages 1681-1685

  Pfaendner, Nadine H ^a   Reuner, Gitta ^a   Pietz, Joachim ^a   Jost, Gregor ^a   Rating, Dietz ^a   Magnotta, Vincent A ^b   Mohr, Alexander ^a   Kress, Bodo ^a   Sartor, Klaus ^a   Hähnel, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ADULT; ARTICLE; BASAL GANGLION; BLOOD LEVEL; BRAIN; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; HIPPOCAMPUS; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENYLKETONURIA; PONS; THALAMUS; BLOOD; CASE CONTROL STUDY; DIET THERAPY; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

ADULT; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PHENYLALANINE; PHENYLKETONURIAS; TIME FACTORS;

EID: 24344447321     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic basis of inherited disease. Vol 1. 17th ed. New York, NY: McGraw-Hill; 1995:1015-1075
2. Brenton DP, Pietz J. Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 2000;159 (suppl 2):S114-S120
3. Magnotta VA, Harris G, Andreasen NC, et al. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 2002;26:251-264
4. Harris G, Andreasen NC, Cizadlo T, et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr 1999;23:144-154
5. Pantel J, O'Leary DS, Cretsinger K, et al. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus 2000;10:752-758
6. Magnotta VA, Heckel D, Andreasen NC, et al. Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology 1999;211:781-790
7. Spinks R, Magnotta VA, Andreasen NC, et al. Manual and automated measurement of the whole thalamus and mediodorsal nucleus using magnetic resonance imaging. Neuroimage 2002;17: 631-642
8. Mitchell TN, Free SL, Merschhemke M, et al. Reliable callosal measurement: population normative data confirm sex-related differences. AJNR Am J Neuroradiol 2003;24:410-418
9. Mohr A, Knauth M, Weisbrod M, et al. [Similarity of the brains of twins]. Rofo 2001;173:515-521
10. Okugawa G, Takase K, Nobuhara K, et al. Inter- and intraoperator reliability of brain tissue measures using magnetic resonance imaging. Eur Arch Psychiatry Clin Neurosci 2003;253:301-306
11. Hsu YY, Schuff N, Du AT, et al. Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging 2002;16:305-310
12. Schnack HG, van Haren NE, Hulshoff Pol HE, et al. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp 2004;22:312-320
13. Dyer CA. Comments on the neuropathology of phenylketonuria. Eur J Pediatr 2000;159(suppl 2):S107-S108
14. Huttenlocher PR. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 2000;159 (suppl 2):S102-S106
15. Dyer CA, Kendler A, Philibotte T, et al. Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol 1996;55:795-814
16. Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679-688
17. Ullrich K, Moller H, Weglage J, et al. White matter abnormalities in phenylketonuria: results of magnetic resonance measurements. Acta Paediatr Suppl 1994;407:78-82
18. Thompson AJ, Tillotson S, Smith I, et al. Brain MRI changes in phenylketonuria: associations with dietary status. Brain 1993;116:811-821
19. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 1994;344:87-90
20. Pearsen KD, Gean-Marton AD, Levy HL, Davis KR. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 1990;177:437-440
21. Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis 2002;13 Suppl 2:53-57
22. Pietz J, Kreis R, Schmidt H, et al. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 1996;201:413-420
23. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995;127:251-255
24. Brenton DP, Tarn AC, Cabrera-Abreu JC, Lilburn M. Phenylketonuria: treatment in adolescence and adult life. Eur J Pediatr 1996;155 (suppl 1):S93-S96
25. 12 deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr 1996;155 (suppl 1):S145-S147
26. Villasana D, Butler IJ, Williams JC, Roongta SM. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 1989;12:451-457
27. Leuzzi V, Trasimeni G, Gualdi GF, Antonozzi I. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients. J Inherit Metab Dis 1995;18:624-634
28. Rupp A, Kreis R, Zschocke J, et al. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. J Cereb Blood Flow Metab 2001;21:276-284
29. Pietz J, Rupp A, Burgard P, et al. No evidence for individual blood-brain barrier phenylalanine transport to influence clinical outcome in typical phenylketonuria patients. Ann Neurol 2002;52: 382-383; reply 383-384
30. Koch R, Moats R, Guttler F, et al. Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 2000;106:1093-1096
31. Weglage J, Wiedermann D, Denecke J, et al. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol 2001;50:463-467
32. Smith I, Beasley MG, Ades AE. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 1991;66:311-316
33. Swayze VW 2nd, Andersen AE, Andreasen NC, et al. Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord 2003;33:33-44
34. Arnold GL, Vladutiu CJ, Kirby RS, et al. Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 2002;141:243-246